Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Vogt

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Pharmacology & Therapeutics|June 1, 2005
Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targetsAndreas Vogt, John S Lazo
Cell Cycle (Georgetown, Tex.)|October 27, 2009
An unusual case of self-defenseAndreas Vogt, John S Lazo
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
Discovery of protein kinase phosphatase inhibitorsAndreas Vogt, John S Lazo
Methods (San Diego, Calif.)|May 29, 2007
Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatasesAndreas Vogt, John S Lazo
Nephron|June 15, 2017
Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney Disease: A Case for Phenotypic Drug Discovery in Acute Kidney InjuryNeil Hukriede, Andreas Vogt, Mark de Caestecker
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Estimation of Arterial Pulse Wave Velocity from Doppler Radar Measurements: a Feasibility StudyRakesh Vasireddy, Josef Goette, Marcel Jacomet, et al.
BMC Pulmonary Medicine|December 12, 2025
Clinical utility of lung diffusing capacity for carbon monoxide (DLco) in children: a retrospective single-center studySrdjan Micic, Andreas Vogt, Alexander Moeller, et al.
Oncology Research|June 23, 2004
A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activityAndreas Vogt, Erica N Kalb, John S Lazo
The Prostate|December 16, 2003
Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cellsKaoru Nemoto, Andreas Vogt, Tetsuya Oguri, et al.
A&A Practice|March 5, 2019
Orthotopic Liver Transplant in a Patient Anticoagulated With Rivaroxaban: A Case ReportPascal H Vuilleumier, Michael Nagler, Guido Beldi, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Pharmacology & Therapeutics|June 1, 2005
Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targetsAndreas Vogt, John S Lazo
Cell Cycle (Georgetown, Tex.)|October 27, 2009
An unusual case of self-defenseAndreas Vogt, John S Lazo
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
Discovery of protein kinase phosphatase inhibitorsAndreas Vogt, John S Lazo
Methods (San Diego, Calif.)|May 29, 2007
Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatasesAndreas Vogt, John S Lazo
Nephron|June 15, 2017
Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney Disease: A Case for Phenotypic Drug Discovery in Acute Kidney InjuryNeil Hukriede, Andreas Vogt, Mark de Caestecker
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Estimation of Arterial Pulse Wave Velocity from Doppler Radar Measurements: a Feasibility StudyRakesh Vasireddy, Josef Goette, Marcel Jacomet, et al.
BMC Pulmonary Medicine|December 12, 2025
Clinical utility of lung diffusing capacity for carbon monoxide (DLco) in children: a retrospective single-center studySrdjan Micic, Andreas Vogt, Alexander Moeller, et al.
Oncology Research|June 23, 2004
A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activityAndreas Vogt, Erica N Kalb, John S Lazo
The Prostate|December 16, 2003
Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cellsKaoru Nemoto, Andreas Vogt, Tetsuya Oguri, et al.
A&A Practice|March 5, 2019
Orthotopic Liver Transplant in a Patient Anticoagulated With Rivaroxaban: A Case ReportPascal H Vuilleumier, Michael Nagler, Guido Beldi, et al.
Pageof 13